Transcatheter Pulmonary Valve Implantation in Carcinoid Heart Disease - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Cardiovascular Revascularization Medicine Année : 2022

Transcatheter Pulmonary Valve Implantation in Carcinoid Heart Disease

Résumé

Carcinoid heart disease is a rare condition affecting mostly tricuspid and pulmonary valves causing right-sided heart failure. Surgical valve replacement is the mainstay of treatment when patients become symptomatic and/or in the presence of right heart remodeling. We present a case of severe pulmonary valve regurgitation secondary to carcinoid heart disease occurring 4 years after a surgical tricuspid replacement, successfully treated with direct transcatheter pulmonary valve implantation without pre-stenting.
Fichier non déposé

Dates et versions

inserm-03831063 , version 1 (26-10-2022)

Identifiants

Citer

M. Flagiello, M. Pozzi, L. Francois, A. Al Harthy, J. Forestier, et al.. Transcatheter Pulmonary Valve Implantation in Carcinoid Heart Disease. Cardiovascular Revascularization Medicine, 2022, 40s, pp.130-134. ⟨10.1016/j.carrev.2021.12.027⟩. ⟨inserm-03831063⟩
18 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More